UBS Group
MSACU

UBS Group’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

UBS Group’s Portfolio MSACU Stock Details MSACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,043
Closed -$50K – 10393
2021
Q1 		$50K Buy
+5,043
New +$51.3K ﹤0.01% 6565

Other funds holding MSACU

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

UBS Group's MSACU Position: Q2 2021 in Review

UBS Group sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 5,043 shares — an estimated $50K sold.

UBS Group first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $50K in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • UBS Group reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 5,043 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $50K.
  • UBS Group first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • UBS Group's Medicus Sciences Acquisition Corp. Unit position peaked at $50K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.